[JD Health (6618 HK) Rating Change]: Strong Profitability Likely Achieved Margin Reversal
⬆ $JD Health(06618)$ - We now take a more positive view on JDH’s ability to at manage the issue at certain periods and certain areas; We raise TP from HK$44 to HK$57 and rating to BUY.
Continue reading on Smartkarma:- https://www.smartkarma.com/insights/jd-health-6618-hk-rating-change-strong-profitability-likely-achieved-margin-reversal?utm_source=tiger_community
By Shawn Yang, Insight Provider on Smartkarma:- https://www.smartkarma.com/profiles/shawn-yang-0668bbf2-2f7c-4383-83ed-5389f1dd9587?utm_source=tiger_community
On JD Health (06618):- https://www.smartkarma.com/entities/jd-health-international-inc?utm_source=tiger_community
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
